Mark Cuban warns Trump's tariffs mean his Cost Plus Drugs ‘won't have a choice' but to raise prices for consumers [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
cofounded, Cost Plus Drugs, would be forced to raise its prices in response to a tariff on goods imported from India. "We won't have a choice," Cuban said. Cuban's company aims to make pharmaceuticals more affordable, with a transparent pricing plan that marks up drug manufacturing costs by 15% and adds a potential pharmacy fee charged by their suppliers (of around $5, plus $5 shipping). But now those prices might go up if the Trump administration imposes tariffs on India, Cuban said. While Cost Drugs Plus won't be affected by tariffs on China, Cuban said any potential tariff on goods imported from India would force the company to raise the price of its medications. In that scenario, he said, Cost Plus Drugs would let consumers know that the cost of tariffs and broker fees would be passed onto them “directly,” with no way for the company to “eat” the costs. The Economic Times reports that the U.S. was India's largest trading partner from 2021 to 2022 and 2023 to 2024, accounti
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA (NYSE:IQV) was given a new $230.00 price target on by analysts at Barclays PLC.MarketBeat
- Amphastar Announces FDA Approval for Teriparatide Injection [Yahoo! Finance]Yahoo! Finance
- Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here's what to know [CNBC]CNBC
- IQVIA: Increasingly Indispensable In Drug Development [Seeking Alpha]Seeking Alpha
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 12/18/25 - Form 144
- 12/9/25 - Form 8-K
- 11/14/25 - Form 3
- IQV's page on the SEC website